McBride Group

Colleen McBride, Ph.D.

Chief & Senior Investigator, Social and Behavioral Research Branch
Head, Public Health Genomics Section

Selected Publications

McBride C.M., Scholes D., Grothaus L., Curry S.J., Albright J. Promoting smoking cessation among women who seek cervical cancer screening. Obstet Gynecol, 91:719-724. 1998. [PubMed]

McBride C.M., Rimer B.K. Using the telephone to improve health behavior and health service delivery. Patient Educ Counsel, 37:3-18. 1999. [PubMed]

McBride C.M., Scholes D., Grothaus L.C., Curry S.J., Ludman E., Albright J. Evaluation of a minimal self-help smoking cessation intervention following cervical cancer screening. Preventive Medicine, 29(2):133-138. 1999. [PubMed]

McBride C.M., Halabi S., Bepler G., McIntyre L., Lipkus I., Albright J., O'Briant K. Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit. Journal of Health Communications, 5:229-241. 2000. [PubMed]

McBride C.M., Bepler G., Lipkus I.M., Lyna P., Samsa G., Albright J., Datta S., Rimer B.K. Incorporating feedback of genetic susceptibility into a smoking cessation intervention for African American smokers with low income. Cancer Epidemiology, Biomarkers and Prevention, 11:521-28. 2002. [PubMed]

McBride C.M., Bastian L.A., Halabi S., Fish L., Lipkus I.M., Bosworth H.B., Rimer B.K, Siegler I.C. Efficacy of a tailored intervention to aid decision-making about hormone replacement therapy. Am J Public Health, 92:1112-1114. 2002. [PubMed]

McBride C.M., Emmons K.M., Lipkus I.M.. Understanding the potential of teachable moments for smoking cessation. Health Education Research, 18(2):156-170. 2003. [PubMed]

Lipkus I.M., McBride C.M., Lyna P., Pollak K.I. Interpretation of genetic risk feedback among African-American smokers with low socioeconomic status. Health Psychology, 23(2):178-88. 2004. [PubMed]

Bepler G., Zheng Z., Guatam A., Sharma S., Cantor A., Sharma A., Cress W.D., Kim Y.C., Rosell R., McBride C., Robinson L., Sommers E., Haura E. Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance. Lung Cancer, 47:183-192. 2005. [PubMed]

McBride C.M. Blazing a trail: a public health research agenda in genomics and chronic disease. Prev Chronic Dis, 2(2):A04. 2005. [PubMed]

McBride C.M., Alford S.H., Reid R.J., Larson E.B., Baxevanis A.D., Brody L.C. Putting science over supposition in the arena of personalized genomics. Nature Genetics, 40(8):939-942. 2008. [PubMed]

Sanderson S.C., O'Neill S.C., White D.B., Lipkus I.M., Bepler G., Bastian L.A., McBride C.M. Responses to online GSTM1 genetic test results amongst smokers related to patients with lung cancer: a pilot study. Cancer Epidemiol Biomarkers Prev, 18(7):1953-61. 2009. [PubMed]

Sanderson S.C., O'Neill S.C., Bastian L.A., Bepler G., McBride C.M. What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer. Public Health Genomics. 2009. [Epub]

Khoury M.J., McBride C.M., Schully S.D., Ioannidis J., Feero W.G., Janssens C., Gwinn M., Simons-Morton D.G., Bernhardt J.M., Cargill M., Chanock S.J., Church G.M., Coates R.J., Collins F.S., Croyle R.T, et al. The scientific foundation for personal genomics: recommendations from an NIH-CDC multidisciplinary workshop. Genet Med, 11(8):559-67. 2009. [PubMed]

McBride C.M., Alford S.H., Reid R.J., Larson E.B., Baxevanis A.D., Brody L. Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genet Med, 11(8):582-7. 2009. [PubMed]

Top of page

Last Reviewed: January 6, 2011